Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists

Summary

Patients on vitamin K antagonists (VKA) often undergo invasive dental procedures. International guidelines consider all dental procedures as low-risk procedures, while bleeding risk may differ between standard low-risk (e. g. extraction 1–3 elements) and extensive high-risk (e.g. extraction of >3 elements) procedures. Therefore current guidelines may need refinement. In this cohort study, we identified predictors of oral cavity bleeding (OCB) and evaluated clinical outcome after low-risk and highrisk dental procedures in patients on VKA. Perioperative management strategy, procedure risk, and 30-day outcomes were assessed for each procedure. We identified 1845 patients undergoing 2004 low-risk and 325 high-risk procedures between 2013 and 2015. OCB occurred after 67/2004 (3.3 %) low-risk and 21/325 (6.5 %) high-risk procedures (p=0.006). In low-risk procedures, VKA continuation with tranexamic acid mouthwash was associated with a lower OCB risk compared to continuation without mouthwash [OR=0.41, 95 %CI 0.23–0.73] or interruption with bridging [OR=0.49, 95 %CI 0.24–1.00], and a similar risk as interruption without bridging [OR=1.44, 95 %CI 0.62–3.64]. In high-risk procedures, VKA continuation was associated with an increased OCB risk compared to interruption [OR=3.08, 95 %CI 1.05–9.04]. Multivariate analyses revealed bridging, antiplatelet therapy, and a supratherapeutic or unobjectified INR before the procedure as strongest predictors of OCB. Non-oral cavity bleeding (NOCB) and thromboembolic event (TE) rates were 2.1 % and 0.2 %. Bridging therapy was associated with a two-fold increased risk of NOCB [OR=1.93, 95 %CI 1.03–3.60], but not with lower TE rates. In conclusion, predictors of OCB were mostly related to perioperative management and differed between low-risk and high-risk procedures. Perioperative management should be differentiated accordingly.

Keywords

Clinical studies - vitamin K antagonist - surgery - risk factors

^* * These authors contributed equally.

• References

• 1 Iwabuchi H, Imai Y, Asanami S. et al. Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study. BMJ open 2014; 4 : e005777-002014-005777.
• 2 Evans IL, Sayers MS, Gibbons AJ. et al. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 2002; 40: 248-252.
• 3 Hong C, Napenas JJ, Brennan M. et al. Risk of postoperative bleeding after dental procedures in patients on warfarin: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: 464-468.
• 4 Ramli R, Abdul Rahman R. Minor oral surgery in anticoagulated patients: local measures alone are sufficient for haemostasis. Singapore Dent J 2005; 27: 13-16.
• 5 van Diermen DE, van der Waal I, Hoogstraten J. Management recommendations for invasive dental treatment in patients using oral antithrombotic medication, including novel oral anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116: 709-716.
• 6 Spyropoulos AC, Al-Badri A, Sherwood MW. et al. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost 2016; 14: 875-85.
• 7 Douketis JD, Spyropoulos AC, Spencer FA. et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e326S-e350S.
• 8 Broekema FL, van Minnen B, Jansma J, Bos R. Risk of bleeding after dentoalveolar surgery in patients taking anticoagulants. Br J Oral Maxillofac Surg 2014; 52: e15-e19.
• 9 Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
• 10 Spyropoulos AC, Douketis JD, Gerotziafas G. et al. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J Thromb Haemost 2012; 10: 692-694.
• 11 Eichhorn W, Burkert J, Vorwig O. et al. Bleeding incidence after oral surgery with continued oral anticoagulation. Clin Oral Invest 2012; 16: 1371-1376.
• 12 Febbo A, Cheng A, Stein B. et al. Postoperative Bleeding Following Dental Extractions in Patients Anticoagulated With Warfarin. J Oral Maxillofac Surg 2016; 74: 1518-1523.
• 13 Kataoka T, Hoshi K, Ando T. Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study. BMJ Open 2016; 6: e010471.
• 14 Braganza A, Bissada N, Hatch C, Ficara A. The effect of non-steroidal anti-inflammatory drugs on bleeding during periodontal surgery. J Periodontol 2005; 76: 1154-1160.
• 15 van Diermen DE, Aartman IH, Baart JA. et al. Dental management of patients using antithrombotic drugs: critical appraisal of existing guidelines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 616-624.
• 16 Ramstrom G, Sindet-Pedersen S, Hall G. et al. Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg 1993; 51: 1211-1216.
• 17 Al-Mubarak S, Al-Ali N, Abou-Rass M. et al. Evaluation of dental extractions, suturing and INR on postoperative bleeding of patients maintained on oral anticoagulant therapy. Br Dent J 2007; 203: E15 discussion 410-411
• 18 Bacci C, Maglione M, Favero L. et al. Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost 2010; 104: 972-975.
• 19 Sindet-Pedersen S, Ramstrom G, Bernvil S, Blomback M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989; 320: 840-843.
• 20 Soares EC, Costa FW, Bezerra TP. et al. Postoperative hemostatic efficacy of gauze soaked in tranexamic acid, fibrin sponge, and dry gauze compression following dental extractions in anticoagulated patients with cardiovascular disease: a prospective, randomized study. Oral Maxillofac Surg 2015; 19: 209-216.
• 21 van Diermen DE, Bruers JJ, Hoogstraten J. et al. Treating dental patients who use antithrombotic medication: a survey of dentists in the Netherlands. J Am Dent Assoc 2011; 142: 1376-1382.
• 22 Eijgenraam P, ten Cate H, ten Cate-Hoek AJ. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding. Neth J Med 2014; 72: 157-164.
• 23 Siegal D, Yudin J, Kaatz S. et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126: 1630-1639.
• 24 Clark NP, Witt DM, Davies LE. et al. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. JAMA Intern Med 2015; 175: 1163-1168.
• 25 Douketis JD, Spyropoulos AC, Kaatz S. et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med 2015; 373: 823-833.
• 26 Dutch Society for Internal Medicine: Guideline antithrombotic therapy. http://richtlijnendatabase.nl/richtlijn/antitrombotisch_beleid/perioperatief_beleid_bij_antistolling.html . Accessed August 15, 2016.